2024 Midwest Radiation Oncology Symposium (Attendee Information)

 In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The University of Nebraska Medical Center designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

The University of Nebraska Medical Center designates this activity for 13.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.

Medical Physicists

This activity has applied to CAMPEP and has been approved for 13.66 MPCEC hours.

Radiation Therapists

This activity has been approved by the American Society of Radiologic Technologists (ASRT) for 16.25 Category A continuing education credits. 

Dosimetrists

This activity is approved by the Medical Dosimetrist Certification Board (MDCB) for 13.00 MDCB continuing education credits

Read the UNMC CCE Disclosure Declaration Policy 

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.

FACULTY

The following have disclosed relevant financial relationships:

• Clifton David Fuller, MD, PhD
  Advisory Service/Honoraria/Travel: Varian Medical Systems, Inc. (A Siemens Healthineers Company)
  Grants/Honoraria/Travel: Elekta
  Honoraria/Travel: Koninklijke Philips N.V.
  Patents/Royalties: Kallisio, Inc.
• Megan Hyun, PhD, DABR
  Speaker's Bureau: Varian Medical Systems, Inc. (A Siemens Healthineers Company)
• Harshraj Leuva, MBBS
  Advisory Board: Astellas Pharma Inc., Seagen Inc.
• Joseph McBride, MD
  Consultant: Integer Holdings Corporation

• Sean McGarry, MD
  Medical Board of Trustees: Musculoskeletal Transplant Foundation (MTF)
• Jeffery Ryckman, MD
  Advisory Board: NewLeaf.ai, Inc.
• Nicole Shonka, MD
  Consultant: GT Medical Technologies, Inc.

• Chi (Kevin) Zhang, MD, PhD*
  Grant: AstraZeneca, BioMimetix Pharma
  Co-founder: ZCure LLC
• Dandan Zheng, PhD, DABR
  Research Agreement: Varian Medical Systems, Inc. (A Siemens Healthineers Company)

 

The following faculty members have nothing to disclose:

• Omar K.M. Abughanimeh, MBBS
• Michele Aizenberg, MD, FAANS, FACS
• Hana Baroudi, MS
• David Berkheim, MD
• Lisa Chaiken, MD
• Serdar Charyyev, PhD
• Jie Chen, MD, PhD
• Yabo Fu, PhD
• Kyle J. Gallagher, PhD, DABR
• Hao Gao, PhD
• Linda M. Huynh, PhD, MSc
• Qateeb Khan, MD
• Mridula Krishnan, MBBS
• Chi Lin, MD, PhD*
• Ruirui Liu, PhD, CHP
• Sara Abou Naej, MS
• Kyuhak Oh, PhD
• Jared P. Schober, MD
• Diane Schott, PhD, DABR
• Andrew Wahl, MD
• Shuo Wang, PhD
• Xiaofeng Yang, PhD, DABR
• Xiandong Zhao, PhD
• Weining (Ken) Zhen, MD, FACR, FASTRO
• Sumin Zhou, PhD

PLANNING COMMITTEE

The following planning committee members have nothing to disclose:

• Michael Baine, MD, PhD
• Dinah Clark
• Valeta Creason-Wahl, HMCC
• Charles Enke, MD, FACR, FASTRO
• Tori Greenlee  
• Julie Huglin  
• Heidi Keeler, PhD, MSN/MBA, RN
• Yu Lei, PhD
• Renee Paulin, MSN, RN, CWOCN
• Brenda Ram, CMP, CHCP
• Hongmei Ren, BSN, RN
• Ann L. Yager, MHA, BS, RT, (R) (T), CT

  

 *Faculty and planning committee member

The following materials (in PDF) are available for download until Sept. 13, 2024. No part of these materials may be reproduced without prior written permission.

Friday, Aug. 23

DEPARTMENT CHAIR WELCOME AND INTRODUCTORY REMARKS

• Unlocking Innovations in Cancer Care - AI in Radiation Oncology
  Charles A. Enke, MD, FASTRO, FACR

KEYNOTE PRESENTATION

• Advances in AI-Based Prediction Models for Radiation Oncology
  Clifton David Fuller, MD, PhD

SESSION 1: GENITOURINARY CANCER I

• Assessing Cancer Treatment Efficacy: The Past, the Present, and the Future!
  Harshraj Leuva, MBBS
• Radiomics: The Intersection of Artificial Intelligence and Prostate Cancer Risk Stratification
  Linda M. Huynh, PhD, MSc

SESSION 2: GENITOURINARY CANCER II

• The Use of Nuclear Imaging in the Workup and Management of a Renal Mass
  Jared P. Schober, MD
• Prostate Cancer Treatment and PSMA PET Imaging: Patterns of Care at June E. Nylen Cancer Center
  Lisa Chaiken, MD

SESSION 3: SARCOMA

• Current and Novel Radiotherapy Approaches to Soft Tissue Sarcoma
  Andrew Wahl, MD
• Surgical Approaches to the Management of Soft Tissue Sarcomas
  Sean McGarry, MD

SESSION 4: BRAIN TUMOR

• Applications of Artificial Intelligence in Brain Tumor Diagnosis
  Jie Chen, MD, PhD
• Repurposing FDA-Approved Drugs for Glioma Therapy
  Nicole Shonka, MD

• Accurate Prediction of Individual Brain Function Maps From Structural Imaging Utilizing Deep Learning
  Michele Aizenberg, MD, FAANS, FACS
• Radiomic-Assisted Imaging Diagnosis of Brain Metastasis: How to Exceed Human Eye Limitations
  Chi (Kevin) Zhang, MD, PhD

SESSION 5: HEPATOCELLULAR CARCINOMA

• Targeting the Core: Yttrium-90 Radioembolization in Hepatocellular Carcinoma Management
  Joseph McBride, MD
• Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma
  Chi Lin, MD, PhD

• Optimizing Treatment Strategies: Immunotherapy in Combination with Local Therapy for Hepatocellular Carcinoma
  Mridula Krishnan, MBBS

Saturday, Aug. 24

KEYNOTE PRESENTATION

• Leveraging AI in Precision Radiotherapy: Advancements in Medical Image Analysis
  Xiaofeng Yang, PhD, DABR

SESSION 6: AI IN RADIOTHERAPY APPLICATION I

• AI-Powered Precision: Real-Time Markerless Tracking in X-Ray Imaging
  Yabo Fu, PhD
• Use of AI to Improve Access to Radiotherapy in Low and Middle-Income Countries (LMICs)
  Hana Baroudi, MS

SESSION 7: FLASH RADIOTHERAPY

• Normal Tissue Sparing via Proton FLASH, Spatially Fractionated Radiation Therapy (SFRT) and Beyond
  Hao Gao, PhD
• G4NDA-Based Radiochemical Monte Carlo Model to Investigate DNA Damage and FLASH Mechanism
  Xiandong Zhao, PhD

SESSION 8: INNOVATION IN MEDICAL PHYSICS EDUCATION

• An International Exchange: Bi-Directional Global Health Rotation for Residency Training Programs in a High-Income Country and a Low- and Middle-Income Country
  Sara Abou Naej, MS
• Innovative Patient Communication Training Using eLearning and Simulation
  Megan Hyun, PhD, DABR

SESSION 9: NON-SMALL CELL LUNG CANCER

• Debunking Myths: Is More Resection Always Better in Stage I Lung Cancer?
  David Berkheim, MD
• SBRT in Centrally-Located Stage I Lung Cancer: Navigating Treatment Challenges
  Qateeb Khan, MD
• Expanding Treatment Horizons: The Role of Immunotherapy in Stage I Lung Cancer
  Omar K. M. Abughanimeh, MBBS
• Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617
  Jeffrey Ryckman, MD

SESSION 10: AI IN RADIOTHERAPY APPLICATION II

• Adaptive Radiotherapy and the Role of Artificial Intelligence
  Dandan Zheng, PhD, DABR
• Towards Developing an AI-Powered Digital Twin Modeling Framework for Personalized Radiotherapy
  Ruirui Liu, PhD, CHP
• Advancements of Artificial Intelligence in Proton Therapy
  Serdar Charyyev, PhD